Clinical-stage biotechnology company developing genetics-informed precision antibody therapeutics for immune and inflammatory diseases
Clinical-stage biotechnology company developing genetics-informed precision antibody therapeutics for immune and inflammatory diseases. It combines human genetics, mechanistic biology, and advanced antibody engineering to identify genetically validated targets and develop functional antibodies, including programs for atopic dermatitis.